Enliven Therapeutics, Inc.

ELVN

—

Advanced chart & tools →

Enliven Therapeutics, Inc.ELVN

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-1.83

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

—

Net income

$-103.69M

Net margin

—

Gross margin

—

Dividends & financials

Enliven Therapeutics, Inc. (ELVN) reported revenue of — and net income of $-103.69M, or $-1.83 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.